School of Medicine

As part of a federal initiative to end the HIV epidemic, Washington University in St. Louis will establish a center to provide guidance and support to local organizations working to reduce HIV infection rates in their communities. Among other things, the center will help organizations provide PrEP, a medicine that prevents HIV infection.

Michael J. Holtzman, MD, director of the School of Medicine’s Division of Pulmonary & Critical Care Medicine, has received awards totaling $7.5 million to support innovative research aimed at defining and controlling chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease.

Welcome to Cortex, an innovation community started in 2002 thanks to a lead investment from Washington University. Drone footage takes you through the formerly blighted industrial complex that is now a hip mixed-use space and home to more than 5,800 jobs. This is Cortex.

Nearly all babies born prematurely receive antibiotics. A new study from the School of Medicine suggests that such early antibiotic treatment could have long-lasting and potentially harmful effects on the gut microbiome.

Caline Mattar, MD, assistant professor of medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis, has been appointed a chair of the Expert Advisory Group for the Global Antimicrobial Resistance Research and Development Hub.

A test for signs of Zika infection has been granted market authorization by the Food and Drug Administration. The test is based in part on an antibody developed by researchers at the School of Medicine.

Richard P. Rood, MD, professor of medicine in the Division of Gastroenterology at the School of Medicine, gave the opening keynote address at the United Ostomy Association of America’s national conference Aug. 7 in Philadelphia.

Researchers at the School of Medicine have developed a way to fluorescently tag cells infected with chikungunya virus. The technique opens up new avenues to study how the virus persists in the body and potentially could lead to a treatment.

Researchers at the School of Medicine in St. Louis and the biotech startup VaxNewMo have developed a vaccine that is effective, in mice, against hypervirulent strains of Klebsiella that can cause life-threatening infections in healthy adults.

Graham A. Colditz, MD, DrPH, the Niess-Gain professor of surgery and director of the Division of Public Health Sciences at Washington University School of Medicine in St. Louis, has been named to the National Institutes of Health (NIH) Council of Councils.